Spasmodic Dysphonia: Description of the Disease and Associated Neurologic Disorders

被引:0
|
作者
Coelho, Marina Serrato [1 ]
Macedo, Evaldo [1 ]
Braz de Oliveira, Marcela Schmidt [1 ]
Lobo, Paulo [1 ]
Soccol, Andrea Thomaz [1 ]
Koerner, Heloisa Nardi [1 ]
机构
[1] Univ Fed Parana, Hosp Clin, Curitiba, Parana, Brazil
关键词
neuromuscular diseases; voice disorders; dysphonia;
D O I
暂无
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Introduction: Spasmodic dysphonia (SD) is a problem that affects speech and vocalization, one of the most devastating disorders of oral communication. It is characterized by vocal quality tensaestrangulada, harshly and / or interspersed with abrupt vocal attack and a great tension in the vocal tract. The etiology of spasmodic dysphonia is unclear. Some authors point to psychogenic causes, neurological or even unknown. Objective: To assess the prevalence of muscular dystonias and other neurological symptoms in patients with ED. Method: A retrospective study of 10 cases with diagnosis of ED for symptoms and neurological disorders associated. Results: There was a significant predominance of the disease in females (9:1). The average age of onset of symptoms was 32 years, ranging between 14 and 60 years. The mean disease duration was 10 years. Among the patients, 87.5% had a diagnosis of disorders of movement made by a neurologist, including orofacial dystonias (50%), essential tremor (50%) and spastic paraparesis (12%). Conclusion: The presence of movement disorders followed almost all cases of spasmodic dysphonia. More studies are needed to clarify the pathophysiological basis of disease.
引用
收藏
页码:163 / 166
页数:4
相关论文
共 50 条
  • [41] Spasmodic dysphonia: introductory phonetic analyses
    Reid, Eric W.
    Nobriga, Christina, V
    CLINICAL LINGUISTICS & PHONETICS, 2023, 37 (10) : 883 - 898
  • [42] Anxiety and depression in spasmodic dysphonia patients
    Hu Amanda
    Hillel Al
    Zhao Wei
    Meyer Tanya
    世界耳鼻咽喉头颈外科杂志(英文), 2018, 4 (02)
  • [43] Postextubation laryngospasm in a patient with spasmodic dysphonia
    Capacchione, JF
    Bodily, K
    Hudson, AJ
    ANESTHESIOLOGY, 2005, 102 (04) : 859 - 860
  • [44] Striatal dopaminergic function in spasmodic dysphonia
    Simonyan, K.
    Herscovitch, P.
    MOVEMENT DISORDERS, 2009, 24 : S111 - S112
  • [45] BOTULINUM TOXIN TREATMENT FOR SPASMODIC DYSPHONIA
    KOBAYASHI, T
    NIIMI, S
    KUMADA, M
    KOSAKI, H
    HIROSE, H
    ACTA OTO-LARYNGOLOGICA, 1993, : 155 - 157
  • [46] Botulinum toxin for the treatment of spasmodic dysphonia
    Gibbs, SR
    Blitzer, A
    OTOLARYNGOLOGIC CLINICS OF NORTH AMERICA, 2000, 33 (04) : 879 - +
  • [47] Disfluency in spasmodic dysphonia: A multivariate analysis
    Cannito, MP
    Burch, AR
    Watts, C
    Rappold, PW
    Hood, SB
    Sherrard, K
    JOURNAL OF SPEECH LANGUAGE AND HEARING RESEARCH, 1997, 40 (03): : 627 - 641
  • [48] Anxiety and depression in spasmodic dysphonia patients
    Amanda Hu
    Al Hillel
    Wei Zhao
    Tanya Meyer
    世界耳鼻咽喉头颈外科杂志英文版, 2018, (02) : 110 - 116
  • [49] Gray matter abnormalities in spasmodic dysphonia
    Simonyan, K.
    Ludlow, C. L.
    MOVEMENT DISORDERS, 2008, 23 (01) : S159 - S160
  • [50] MEDICAL EVALUATION OF PATIENTS WITH SPASMODIC DYSPHONIA
    SWENSON, MR
    ZWIRNER, P
    MURRY, T
    WOODSON, GE
    JOURNAL OF VOICE, 1992, 6 (04) : 320 - 324